By Nascent Biotech Posted January 14, 2015 In HAH_2015_CFP_Leaflet-22015-01-142015-01-14http://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.pngNascent Biotechhttp://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.png200px200px 0 HAH_2015_CFP_Leaflet-2 Recent PostsNascent Announces the Completion of Its Phase 1 Clinical TrialsNascent Completes Dosing Requirement in Final Cohort of Phase I Clinical TrialNBIO Fits Profile for Strategy Targeting Early Stage BiotechNascent Enrolls Final Patient Cohort in Phase I Brain Cancer Trial
